Reuters logo
4 months ago
BRIEF-Novartis says U.S. wholesale acquisition cost of Rydapt for AML indication to be $7,495 for 14-day package
April 28, 2017 / 5:05 PM / 4 months ago

BRIEF-Novartis says U.S. wholesale acquisition cost of Rydapt for AML indication to be $7,495 for 14-day package

April 28 (Reuters) - Novartis AG:

* Says U.S. wholesale acquisition cost of Rydapt for AML indication is $7,495 for 14-day package and $14,990 for 28-day package - spokeswoman Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below